CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | fullerene |
|
Accession: | CHEBI:33416
|
browse the term
|
Definition: | A compound composed solely of an even number of carbon atoms, which form a cage-like fused-ring polycyclic system with twelve five-membered rings and the rest six-membered rings. The term has been broadened to include any closed cage structure consisting entirely of three-coordinate carbon atoms. |
Synonyms: | exact_synonym: | fullerenes |
| related_synonym: | Fulleren; fulereno; fulerenos; fullereno; fullerenos |
|
|
|
G |
1700009N14Rikl |
RIKEN cDNA 1700009N14 gene like |
increases expression |
EXP |
fullerene C60 results in increased expression of 1700009N14RIKL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:54,456,005...54,457,381
Ensembl chr 5:54,455,893...54,457,677
|
|
G |
Aaas |
aladin WD repeat nucleoporin |
increases expression |
EXP |
fullerene C60 results in increased expression of AAAS mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:133,464,315...133,483,961
Ensembl chr 7:133,464,315...133,483,961
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ABCE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:45,109,880...45,134,819
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Abcf3 |
ATP binding cassette subfamily F member 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ABCF3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:80,339,977...80,352,211
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
increases expression |
EXP |
fullerene C60 results in increased expression of ABHD8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,178,441...18,185,178
Ensembl chr16:18,144,464...18,157,667
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
increases expression |
EXP |
fullerene C60 results in increased expression of ABL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Abl2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ABL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:71,223,902...71,319,770
Ensembl chr13:68,673,722...68,839,742
|
|
G |
Ablim2 |
actin binding LIM protein family, member 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of ABLIM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:79,090,046...79,214,986
Ensembl chr14:74,866,281...74,990,334
|
|
G |
Abra |
actin-binding Rho activating protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ABRA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:72,970,187...72,974,255
Ensembl chr 7:72,970,186...72,974,255
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACAA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACACA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of ACBD4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACER2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Ache |
acetylcholinesterase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACHE mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ACOT1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acp4 |
acid phosphatase 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACP4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:94,736,376...94,751,871
Ensembl chr 1:94,735,514...94,744,623
|
|
G |
Acp6 |
acid phosphatase 6, lysophosphatidic |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACP6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:184,711,619...184,733,017
|
|
G |
Actl7a |
actin-like 7a |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACTL7A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:76,242,201...76,245,647
Ensembl chr 5:71,447,071...71,450,908
|
|
G |
Actl7b |
actin-like 7b |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACTL7B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:71,445,532...71,446,920
Ensembl chr 5:71,445,534...71,446,920
|
|
G |
Actn4 |
actinin alpha 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACTN4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actrt2 |
actin-related protein T2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ACTRT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:170,518,470...170,519,870
Ensembl chr 5:165,236,086...165,237,629
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ACY1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADAM19 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam7 |
ADAM metallopeptidase domain 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADAM7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADAM8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adamtsl2 |
ADAMTS-like 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADAMTSL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:10,404,626...10,434,554
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADARB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Adcy7 |
adenylate cyclase 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADCY7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:18,740,875...18,776,311
|
|
G |
Add1 |
adducin 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adgre5 |
adhesion G protein-coupled receptor E5 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADGRE5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADHFE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adora1 |
adenosine A1 receptor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADORA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADRA1B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADRA1D mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADRA2A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADRA2B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ADRA2C mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:75,471,143...75,472,846
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ADRB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Aebp1 |
AE binding protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AEBP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:84,951,577...84,962,840
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AFF4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AGAP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958
|
|
G |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of AGAP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:10,674,746...10,724,848
Ensembl chr 4:10,674,064...10,725,244
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
ISO |
[[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein |
CTD |
PMID:31504961 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ahctf1 |
AT hook containing transcription factor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AHCTF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AHCYL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:195,294,153...195,345,815
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AHR mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm2 |
AIF family member 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of AIFM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:30,195,781...30,222,014
Ensembl chr20:29,652,927...29,679,236
|
|
G |
Akap3 |
A-kinase anchoring protein 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AKAP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:159,699,289...159,713,903
|
|
G |
Akna |
AT-hook transcription factor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AKNA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
|
|
G |
Aknad1 |
AKNA domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AKNAD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:196,385,149...196,432,319
Ensembl chr 2:196,393,535...196,432,309
|
|
G |
Akr1b1-ps1 |
aldo-keto reductase family 1, member B1 (aldose reductase), pseudogene 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AKR1B1-PS1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:45,089,717...45,090,928
Ensembl chr 6:45,089,864...45,090,767
|
|
G |
Akr1c12l1 |
aldo-keto reductase family 1, member C12-like 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AKR1C12L1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:65,937,834...65,948,344
Ensembl chr17:65,937,814...65,997,595 Ensembl chr17:65,937,814...65,997,595
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AKT1S1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of AKT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein]; fullerene C60 promotes the reaction [ALB protein modified form results in increased expression of TNF protein] |
CTD |
PMID:19376187 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh16a1 |
aldehyde dehydrogenase 16 family, member A1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ALDH16A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
EXP |
fullerene C60 results in increased expression of ALOX15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Als2cl |
ALS2 C-terminal like |
increases expression |
EXP |
fullerene C60 results in increased expression of ALS2CL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
|
|
G |
Alx3 |
ALX homeobox 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ALX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:197,919,381...197,929,795
Ensembl chr 2:195,231,197...195,241,609
|
|
G |
Ambn |
ameloblastin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AMBN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:19,601,761...19,614,382
Ensembl chr14:19,601,702...19,614,393
|
|
G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AMIGO1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:198,511,285...198,516,744
Ensembl chr 2:195,823,042...195,829,585
|
|
G |
Amn |
amnion associated transmembrane protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AMN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:136,132,567...136,140,008
Ensembl chr 6:130,311,372...130,318,815
|
|
G |
Ampd2 |
adenosine monophosphate deaminase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AMPD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd13a |
ankyrin repeat domain 13a |
increases expression |
EXP |
fullerene C60 results in increased expression of ANKRD13A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:47,458,828...47,488,959
Ensembl chr12:41,798,199...41,829,327
|
|
G |
Ankrd33b |
ankyrin repeat domain 33B |
increases expression |
EXP |
fullerene C60 results in increased expression of ANKRD33B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
|
|
G |
Anks1a |
ankyrin repeat and sterile alpha motif domain containing 1A |
increases expression |
EXP |
fullerene C60 results in increased expression of ANKS1A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,963,678...6,117,148
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
EXP |
fullerene C60 results in increased expression of ANPEP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
EXP |
fullerene C60 results in increased expression of ANXA6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AP1B1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap1m1 |
adaptor related protein complex 1 subunit mu 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of AP1M1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,584,730...17,602,403
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AP1S1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:25,261,958...25,272,483
Ensembl chr12:19,625,332...19,756,713
|
|
G |
Ap2a1 |
adaptor related protein complex 2 subunit alpha 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AP2A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:95,384,309...95,414,147
|
|
G |
Apba2 |
amyloid beta precursor protein binding family A member 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of APBA2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699
|
|
G |
Apc2 |
APC regulator of WNT signaling pathway 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of APC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression increases expression |
EXP |
fullerene C60 results in decreased expression of APOA1 mRNA fullerene C60 results in increased expression of APOA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa5 |
apolipoprotein A5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of APOA5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apol9a |
apolipoprotein L9a |
decreases expression |
EXP |
fullerene C60 results in decreased expression of APOL9A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of APOLD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:167,818,271...167,825,706
|
|
G |
Aqp11 |
aquaporin 11 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AQP11 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:152,046,517...152,056,725
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
EXP |
fullerene C60 results in increased expression of AQP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Arfip2 |
ARF interacting protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARFIP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:169,387,484...169,392,290
Ensembl chr 1:159,974,201...159,980,336
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARG2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap10 |
Rho GTPase activating protein 10 |
affects expression |
EXP |
fullerene C60 affects the expression of ARHGAP10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313
|
|
G |
Arhgap25 |
Rho GTPase activating protein 25 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARHGAP25 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:119,896,844...119,974,982
|
|
G |
Arhgap27 |
Rho GTPase activating protein 27 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGAP27 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:88,780,527...88,813,275
Ensembl chr10:88,280,455...88,313,185
|
|
G |
Arhgap31 |
Rho GTPase activating protein 31 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGAP31 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
|
|
G |
Arhgap33 |
Rho GTPase activating protein 33 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARHGAP33 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:85,776,112...85,789,767
Ensembl chr 1:85,776,108...85,789,678
|
|
G |
Arhgef11 |
Rho guanine nucleotide exchange factor 11 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGEF11 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGEF12 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
|
|
G |
Arhgef18 |
Rho/Rac guanine nucleotide exchange factor 18 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGEF18 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:1,395,035...1,503,082
Ensembl chr12:1,395,088...1,503,081
|
|
G |
Arhgef28 |
Rho guanine nucleotide exchange factor 28 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGEF28 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672
|
|
G |
Arhgef37 |
Rho guanine nucleotide exchange factor 37 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARHGEF37 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARHGEF4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:36,861,835...37,005,075
|
|
G |
Arhgef7 |
Rho guanine nucleotide exchange factor 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARHGEF7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:84,373,123...84,484,759
Ensembl chr16:77,671,023...77,782,697
|
|
G |
Arid3b |
AT-rich interaction domain 3B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARID3B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:67,089,141...67,136,764
Ensembl chr 8:58,193,418...58,238,318
|
|
G |
Arl4d |
ARF like GTPase 4D |
affects expression |
EXP |
fullerene C60 affects the expression of ARL4D mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Armc6 |
armadillo repeat containing 6 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARMC6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARMCX1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:102,192,225...102,196,130
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Armcx6 |
armadillo repeat containing, X-linked 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARMCX6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:102,222,288...102,229,871
Ensembl chr X:97,929,041...97,931,977
|
|
G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ARPC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:75,820,770...75,851,471
|
|
G |
Arrdc2 |
arrestin domain containing 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of ARRDC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029
|
|
G |
Arsb |
arylsulfatase B |
increases expression |
EXP |
fullerene C60 results in increased expression of ARSB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Arsl |
arylsulfatase L |
increases expression |
EXP |
fullerene C60 results in increased expression of ARSL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ASB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376
|
|
G |
Asb6 |
ankyrin repeat and SOCS box-containing 6 |
increases expression |
EXP |
fullerene C60 results in increased expression of ASB6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:14,110,628...14,115,274
Ensembl chr 3:14,110,628...14,115,242
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ASGR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:55,274,299...55,278,323
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Ash1l |
ASH1 like histone lysine methyltransferase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ASH1L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:174,346,150...174,483,055
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ASIC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Asic4 |
acid sensing ion channel subunit family member 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ASIC4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:76,941,532...76,962,900
Ensembl chr 9:76,941,532...76,962,900
|
|
G |
Ate1 |
arginyltransferase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:184,963,562...185,080,908
|
|
G |
Atf6 |
activating transcription factor 6 |
affects expression |
EXP |
fullerene C60 affects the expression of ATF6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ATG16L1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:95,869,839...95,905,354
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atp13a2 |
ATPase cation transporting 13A2 |
increases expression |
EXP |
fullerene C60 results in increased expression of ATP13A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:158,575,727...158,595,157
Ensembl chr 5:153,292,751...153,312,139
|
|
G |
Atp1b3 |
ATPase Na+/K+ transporting subunit beta 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP1B3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:96,910,309...96,941,598 Ensembl chr 8:96,910,309...96,941,598
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP2A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of ATP2A3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP5MC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:133,791,342...133,799,733
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP5MC3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
affects expression |
EXP |
fullerene C60 affects the expression of ATP6AP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:12,856,708...12,883,670
Ensembl chr X:10,183,068...10,210,918
|
|
G |
Atp6v0a1 |
ATPase H+ transporting V0 subunit a1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP6V0A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:85,935,854...85,989,895
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP6V0D1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Atp6v0e2 |
ATPase, H+ transporting V0 subunit e2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ATP6V0E2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:77,482,226...77,488,777
|
|
G |
Atxn2l |
ataxin 2-like |
increases expression |
EXP |
fullerene C60 results in increased expression of ATXN2L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:181,078,293...181,090,079
Ensembl chr 1:181,078,288...181,089,686
|
|
G |
Avp |
arginine vasopressin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AVP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Avpr2 |
arginine vasopressin receptor 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of AVPR2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:156,785,009...156,787,477
Ensembl chr X:151,633,522...151,635,989
|
|
G |
Axin2 |
axin 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of AXIN2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of B3GAT1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:33,362,791...33,390,446
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of B4GALNT4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294
|
|
G |
B4galt2 |
beta-1,4-galactosyltransferase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of B4GALT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:131,412,541...131,422,573
Ensembl chr 5:131,412,541...131,421,013
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BASP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Baz2a |
bromodomain adjacent to zinc finger domain, 2A |
increases expression |
EXP |
fullerene C60 results in increased expression of BAZ2A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:1,107,377...1,145,507
Ensembl chr 7:523,265...560,659
|
|
G |
Bbs1 |
Bardet-Biedl syndrome 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of BBS1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:202,186,125...202,204,086
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BBS4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:59,731,912...59,765,607
|
|
G |
Bbx |
BBX high mobility group box domain containing |
affects expression |
EXP |
fullerene C60 affects the expression of BBX mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:63,850,034...64,097,700
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
increases expression |
EXP |
fullerene C60 results in increased expression of BCAM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
increases expression |
EXP |
fullerene C60 results in increased expression of BCAR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
increases expression |
EXP |
fullerene C60 results in increased expression of BCAS3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,214,098...70,673,080
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BCKDHB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BCL2L10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:76,107,326...76,113,367
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BCO1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:62,058,061...62,094,923
Ensembl chr19:45,149,265...45,186,101
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of BDH1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BDNF mRNA; fullerene C60 results in decreased expression of BDNF protein |
CTD |
PMID:29191454 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of BEAN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537
|
|
G |
Best2 |
bestrophin 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BEST2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:40,047,191...40,053,216
Ensembl chr19:23,141,602...23,148,339
|
|
G |
Bex3 |
brain expressed X-linked 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BEX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:104,064,896...104,066,425
Ensembl chr X:99,273,161...99,274,800
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BICD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:182,479,071...182,627,434
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BMP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Borcs8 |
BLOC-1 related complex subunit 8 |
increases expression |
EXP |
fullerene C60 results in increased expression of BORCS8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BPGM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BRCC3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BSN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Btbd10 |
BTB domain containing 10 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BTBD10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:176,865,817...176,923,663
Ensembl chr 1:167,431,329...167,489,916
|
|
G |
Btbd2 |
BTB domain containing 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of BTBD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344
|
|
G |
Bud13 |
BUD13 homolog |
decreases expression |
EXP |
fullerene C60 results in decreased expression of BUD13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958
|
|
G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of C1GALT1C1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:122,243,736...122,248,217
Ensembl chr X:117,375,525...117,382,787
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of C1QC mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1qtnf1 |
C1q and TNF related 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of C1QTNF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:104,159,021...104,180,253
Ensembl chr10:103,660,327...103,681,660
|
|
G |
C2 |
complement C2 |
increases expression |
EXP |
fullerene C60 results in increased expression of C2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of C2CD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
|
|
G |
C2cd2l |
C2CD2-like |
increases expression |
EXP |
fullerene C60 results in increased expression of C2CD2L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:53,544,887...53,557,127
Ensembl chr 8:44,648,079...44,658,340
|
|
G |
C2cd4d |
C2 calcium-dependent domain containing 4D |
increases expression |
EXP |
fullerene C60 results in increased expression of C2CD4D mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:181,999,778...182,001,941
Ensembl chr 2:181,997,078...182,002,087
|
|
G |
C6 |
complement C6 |
increases expression |
EXP |
fullerene C60 results in increased expression of C6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CABLES1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,075,524...3,181,181
|
|
G |
Cachd1 |
cache domain containing 1 |
affects expression |
EXP |
fullerene C60 affects the expression of CACHD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:120,527,224...120,752,685
Ensembl chr 5:115,411,071...115,657,505
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CACNA1D mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Cacna1e |
calcium voltage-gated channel subunit alpha1 E |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CACNA1E mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:69,125,048...69,613,795
Ensembl chr13:66,581,920...66,894,450
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CACNA1G mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CACNA1I mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CACNA2D3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,098,445...4,912,351
|
|
G |
Calb2 |
calbindin 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CALB2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:55,023,849...55,050,858
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CALM3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calml3 |
calmodulin-like 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CALML3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:71,329,438...71,333,068
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Caly |
calcyon neuron-specific vesicular protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CALY mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551
|
|
G |
Camk1g |
calcium/calmodulin-dependent protein kinase IG |
increases expression |
EXP |
fullerene C60 results in increased expression of CAMK1G mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CAMK4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Canx |
calnexin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CANX mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Capn1 |
calpain 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CAPN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CAR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car5a |
carbonic anhydrase 5A |
increases expression |
EXP |
fullerene C60 results in increased expression of CA5A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:66,881,678...66,911,486
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Card10 |
caspase recruitment domain family, member 10 |
increases expression |
EXP |
fullerene C60 results in increased expression of CARD10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:110,330,408...110,359,224
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CARM1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Cartpt |
CART prepropeptide |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CARTPT mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Caskin2 |
cask-interacting protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CASKIN2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:101,027,196...101,041,429
Ensembl chr10:101,027,260...101,041,414
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases activity |
ISO |
fullerene C60 analog results in increased cleavage of CASP3 protein fullerene C60 metabolite results in increased activity of CASP3 protein |
CTD |
PMID:18926839 PMID:22108244 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8ap2 |
caspase 8 associated protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CASP8AP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
|
|
G |
Cat |
catalase |
decreases activity |
ISO |
fullerene C60 metabolite results in decreased activity of CAT protein |
CTD |
PMID:22108244 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav3 |
caveolin 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CAV3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:145,582,060...145,598,137
|
|
G |
Cbfa2t2 |
CBFA2/RUNX1 partner transcriptional co-repressor 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CBFA2T2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:163,397,160...163,503,409
Ensembl chr 3:142,936,985...143,043,197
|
|
G |
Cbfb |
core-binding factor subunit beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CBFB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:49,955,133...50,002,661
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Cby2 |
chibby family member 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CBY2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:50,909,435...51,004,449
Ensembl chr15:50,909,436...50,934,633
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCDC124 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
|
|
G |
Ccdc136 |
coiled-coil domain containing 136 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCDC136 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:57,997,853...58,027,646
|
|
G |
Ccdc187 |
coiled-coil domain containing 187 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCDC187 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:9,070,192...9,127,001
Ensembl chr 3:9,070,185...9,126,946
|
|
G |
Ccdc22 |
coiled-coil domain containing 22 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCDC22 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:17,570,184...17,582,130
Ensembl chr X:14,898,296...14,910,244
|
|
G |
Ccdc33 |
coiled-coil domain containing 33 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCDC33 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:58,434,798...58,534,338
Ensembl chr 8:58,435,661...58,534,370
|
|
G |
Ccdc60 |
coiled-coil domain containing 60 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCDC60 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:40,314,687...40,480,338
Ensembl chr12:40,314,713...40,480,225
|
|
G |
Ccdc77 |
coiled-coil domain containing 77 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCDC77 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:153,534,184...153,566,059
Ensembl chr 4:153,534,187...153,566,545
|
|
G |
Ccdc91 |
coiled-coil domain containing 91 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCDC91 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:180,402,327...180,574,364
Ensembl chr 4:180,402,376...180,574,364
|
|
G |
Ccdc9b |
coiled-coil domain containing 9B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCDC9B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:126,190,039...126,198,931
Ensembl chr 3:105,739,174...105,744,697
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCHCR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL12 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL17 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCL19 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL2 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL22 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,257,601...10,264,400
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL3 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL7 mRNA |
CTD |
PMID:19167457 PMID:20471445 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCL6 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccm2 |
CCM2 scaffold protein |
increases expression |
EXP |
fullerene C60 results in increased expression of CCM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:81,418,418...81,464,114
Ensembl chr14:81,418,236...81,464,116
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CCN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccnf |
cyclin F |
increases expression |
EXP |
fullerene C60 results in increased expression of CCNF mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccnl1 |
cyclin L1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCNL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCR9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:132,273,581...132,287,651
Ensembl chr 8:123,395,813...123,413,969
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
increases expression |
EXP |
fullerene C60 results in increased expression of CCT6A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:32,508,842...32,519,072
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CCT7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:117,989,232...118,006,580
|
|
G |
Cd19 |
CD19 molecule |
increases expression |
EXP |
fullerene C60 results in increased expression of CD19 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd6 |
Cd6 molecule |
increases expression |
EXP |
fullerene C60 results in increased expression of CD6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:207,442,877...207,481,634
|
|
G |
Cd7 |
Cd7 molecule |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CD7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:106,304,046...106,306,963
Ensembl chr10:106,304,056...106,306,967
|
|
G |
Cd79b |
CD79b molecule |
increases expression |
EXP |
fullerene C60 results in increased expression of CD79B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,239,356...91,242,625
|
|
G |
Cdc25b |
cell division cycle 25B |
increases expression |
EXP |
fullerene C60 results in increased expression of CDC25B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc42bpb |
CDC42 binding protein kinase beta |
increases expression |
EXP |
fullerene C60 results in increased expression of CDC42BPB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:130,333,712...130,416,377
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
EXP |
fullerene C60 results in increased expression of CDC42BPG mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:213,037,603...213,057,764
Ensembl chr 1:203,608,574...203,628,502
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:185,494,692...185,502,519
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdh16 |
cadherin 16 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CDH16 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
|
|
G |
Cdk11b |
cyclin-dependent kinase 11B |
increases expression |
EXP |
fullerene C60 results in increased expression of CDK11B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:171,495,042...171,521,143
Ensembl chr 5:166,212,829...166,238,876
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CDK14 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk18 |
cyclin-dependent kinase 18 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CDK18 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:46,107,763...46,140,705
Ensembl chr13:43,556,748...43,588,525
|
|
G |
Cdk2ap1 |
cyclin-dependent kinase 2 associated protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CDK2AP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:37,910,718...37,919,446
Ensembl chr12:32,249,747...32,258,479
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression |
EXP ISO |
fullerene C60 results in decreased expression of CDKN1A mRNA fullerene C60 analog results in increased expression of CDKN1A protein |
CTD |
PMID:19167457 PMID:20045429 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
fullerene C60 analog results in increased expression of CDKN2A protein |
CTD |
PMID:20045429 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdon |
cell adhesion associated, oncogene regulated |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CDON mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:33,806,183...33,859,033
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CDT1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CEACAM20 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:88,750,010...88,771,679
Ensembl chr 1:79,622,077...79,643,782
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
EXP |
fullerene C60 results in increased expression of CEBPA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CEBPB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CEBPD mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Celf5 |
CUGBP, Elav-like family member 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CELF5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
affects expression |
EXP |
fullerene C60 affects the expression of CEMIP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:219,337,985...219,407,760
|
|
G |
Cep164 |
centrosomal protein 164 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CEP164 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
|
|
G |
Cep89 |
centrosomal protein 89 |
increases expression |
EXP |
fullerene C60 results in increased expression of CEP89 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
|
|
G |
Cfap126 |
cilia and flagella associated protein 126 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CFAP126 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:86,059,142...86,075,034
Ensembl chr13:83,526,657...83,542,552
|
|
G |
Cfap210 |
cilia and flagella associated protein 210 |
increases expression |
EXP |
fullerene C60 results in increased expression of CFAP210 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
|
|
G |
Chad |
chondroadherin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHAD mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHRAC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:106,901,841...106,905,441
Ensembl chr 7:105,013,015...105,017,136
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHRM1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHRM4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
|
|
G |
Chrng |
cholinergic receptor nicotinic gamma subunit |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHRNG mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Chst1 |
carbohydrate sulfotransferase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CHST1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883
|
|
G |
Chst15 |
carbohydrate sulfotransferase 15 |
increases expression |
EXP |
fullerene C60 results in increased expression of CHST15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:187,028,970...187,107,707
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CHST2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chst6 |
carbohydrate sulfotransferase 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CHST5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Cit |
citron rho-interacting serine/threonine kinase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CIT mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:46,263,881...46,425,642
Ensembl chr12:40,605,563...40,763,860
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CITED2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cklf |
chemokine-like factor |
increases expression |
EXP |
fullerene C60 results in increased expression of CKLF mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570
|
|
G |
Ckm |
creatine kinase, M-type |
affects expression |
EXP |
fullerene C60 affects the expression of CKM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CLCF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CLDN12 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cldn15 |
claudin 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CLDN15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:25,334,849...25,345,104
Ensembl chr12:19,698,337...19,706,819
|
|
G |
Cldn23 |
claudin 23 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CLDN23 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
|
|
G |
Cldn8 |
claudin 8 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CLDN8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:41,362,081...41,364,330
Ensembl chr11:27,875,692...27,878,513
|
|
G |
Cldn9 |
claudin 9 |
increases expression |
EXP |
fullerene C60 results in increased expression of CLDN9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:12,714,137...12,715,568
|
|
G |
Clec4a1 |
C-type lectin domain family 4, member A1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CLEC4A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:157,845,811...157,857,926
Ensembl chr 4:156,173,894...156,186,008
|
|
G |
Clip3 |
CAP-GLY domain containing linker protein 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CLIP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:85,547,170...85,563,187
Ensembl chr 1:85,547,206...85,563,184
|
|
G |
Clptm1 |
CLPTM1 regulator of GABA type A receptor forward trafficking |
increases expression |
EXP |
fullerene C60 results in increased expression of CLPTM1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:79,289,477...79,321,092
|
|
G |
Clvs1 |
clavesin 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CLVS1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:22,408,384...22,604,281
Ensembl chr 5:22,408,384...22,604,270
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CNGB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,726,595...9,791,173
|
|
G |
Cnih1 |
cornichon family member 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CNIH1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:20,037,885...20,049,857
Ensembl chr15:20,037,885...20,049,761
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CNN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnot4 |
CCR4-NOT transcription complex, subunit 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of CNOT4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:63,712,770...63,814,355
Ensembl chr 4:63,712,770...63,814,360
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CNP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CNPPD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:84,082,148...84,088,888
Ensembl chr 9:76,633,477...76,640,188
|
|
G |
Cnpy3 |
canopy FGF signaling regulator 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CNPY3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:14,233,428...14,247,831
|
|
G |
Coa3 |
cytochrome C oxidase assembly factor 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COA3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,220,194...86,221,178
|
|
G |
Coch |
cochlin |
increases expression |
EXP |
fullerene C60 results in increased expression of COCH mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COL10A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:39,737,536...39,744,518
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col20a1 |
collagen type XX alpha 1 chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COL20A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:168,102,475...168,134,759
Ensembl chr 3:168,084,560...168,135,309
|
|
G |
Col23a1 |
collagen type XXIII alpha 1 chain |
increases expression |
EXP |
fullerene C60 results in increased expression of COL23A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:36,050,327...36,337,279
Ensembl chr10:35,549,113...35,836,314
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COL2A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
increases expression |
EXP |
fullerene C60 results in increased expression of COL4A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
EXP |
fullerene C60 results in increased expression of COL5A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
increases expression |
EXP |
fullerene C60 results in increased expression of COL7A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COL8A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COMTD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COPS5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:9,192,100...9,210,731
|
|
G |
Copz1 |
COPI coat complex subunit zeta 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COPZ1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:134,409,799...134,435,662
|
|
G |
Coq8a |
coenzyme Q8A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COQ8A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:94,436,680...94,465,535
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Coro1a |
coronin 1A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CORO1A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of COX6A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Cpa2 |
carboxypeptidase A2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CPA2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:59,160,357...59,183,677
Ensembl chr 4:59,160,357...59,183,674
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CPEB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:135,300,461...135,409,760
|
|
G |
Cplx2 |
complexin 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CPLX2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,222,347...10,293,855
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
EXP |
fullerene C60 results in increased expression of CRAT mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CREBBP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CRLF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,924,722...18,935,997
|
|
G |
Crtc2 |
CREB regulated transcription coactivator 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CRTC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:178,007,233...178,017,397
Ensembl chr 2:175,709,644...175,719,763
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CRY2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Crybb1 |
crystallin, beta B1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CRYBB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CRYM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csde1 |
cold shock domain containing E1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of UNR mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:193,234,546...193,271,301
Ensembl chr 2:190,554,980...190,582,784
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CSF1R mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CSF2RB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:109,886,425...109,904,157
|
|
G |
Csnk1g2 |
casein kinase 1, gamma 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CSNK1G2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:9,727,430...9,746,341
Ensembl chr 7:9,076,740...9,095,052
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CSNK2A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Cstf1 |
cleavage stimulation factor subunit 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CSTF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300
|
|
G |
Cstf2t |
cleavage stimulation factor subunit 2, tau variant |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CSTF2T mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:228,952,617...228,956,183
Ensembl chr 1:228,952,504...228,955,873
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CTDNEP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:54,704,148...54,713,781
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CTNNB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctrb1 |
chymotrypsinogen B1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CTRB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:39,652,931...39,657,689
Ensembl chr19:39,652,933...39,657,688
|
|
G |
Cts7l2 |
cathepsin 7 like 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CTS7L2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:3,903,602...3,907,088
Ensembl chr17:3,903,602...3,906,568
|
|
G |
Ctsk |
cathepsin K |
increases expression |
EXP |
fullerene C60 results in increased expression of CTSK mRNA |
CTD |
PMID:20471445 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ctxn1 |
cortexin 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CTXN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:7,408,308...7,409,919
|
|
G |
Cuedc1 |
CUE domain containing 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CUEDC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:72,892,637...72,986,546
Ensembl chr10:72,892,637...72,986,542
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CXCL1 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CXCL2 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CXCL3 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
increases expression |
EXP |
fullerene C60 results in increased expression of CXCL5 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyb5d1 |
cytochrome b5 domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYB5D1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:54,612,230...54,616,375
Ensembl chr10:54,113,438...54,117,911
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYB5R3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYBA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP11B3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2A3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2B15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2B13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2B3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2E1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of CYP2U1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:219,849,407...219,866,882
|
|
G |
Cyrib |
CYFIP related Rac1 interactor B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYRIB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:97,524,941...97,649,846
Ensembl chr 7:95,633,876...95,697,686
|
|
G |
Cytl1 |
cytokine like 1 |
affects expression |
EXP |
fullerene C60 affects the expression of CYTL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886
|
|
G |
Cyyr1 |
cysteine and tyrosine rich 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of CYYR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:24,557,620...24,664,007
Ensembl chr11:24,515,316...24,663,961
|
|
G |
D2hgdh |
D-2-hydroxyglutarate dehydrogenase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of D2HGDH mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:94,350,555...94,368,384
Ensembl chr 9:94,350,576...94,368,382
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of DACT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dagla |
diacylglycerol lipase, alpha |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DAGLA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:216,315,515...216,372,219
Ensembl chr 1:206,890,638...206,947,232
|
|
G |
Dbh |
dopamine beta-hydroxylase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DBH mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
affects expression |
EXP |
fullerene C60 affects the expression of DBNDD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:173,634,551...173,639,999
Ensembl chr 3:153,191,090...153,220,651
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
fullerene C60 results in increased expression of DBP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dcaf1 |
DDB1 and CUL4 associated factor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DCAF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:116,344,927...116,419,329
Ensembl chr 8:107,474,312...107,540,627
|
|
G |
Dcaf15 |
DDB1 and CUL4 associated factor 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DCAF15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277
|
|
G |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DCAF6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:80,159,282...80,260,510
Ensembl chr13:77,626,307...77,727,512
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DCLK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Dcst1 |
DC-STAMP domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DCST1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:177,063,083...177,079,914
Ensembl chr 2:174,765,350...174,781,806
|
|
G |
Dctn1 |
dynactin subunit 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of DCTN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:115,671,024...115,703,824
Ensembl chr 4:115,661,638...115,703,815
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DDIT4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DDX1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:35,996,469...36,027,365
|
|
G |
Ddx11 |
DEAD/H-box helicase 11 |
increases expression |
EXP |
fullerene C60 results in increased expression of DDX11 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:105,833,504...105,862,550
|
|
G |
Ddx23 |
DEAD-box helicase 23 |
increases expression |
EXP |
fullerene C60 results in increased expression of DDX23 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DDX24 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DDX3X mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:12,152,346...12,165,983
Ensembl chr X:9,479,532...9,493,168
|
|
G |
Def8 |
differentially expressed in FDCP 8 homolog |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DEF8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638
|
|
G |
Defb22 |
defensin beta 22 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DEFB22 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:161,417,380...161,421,659
Ensembl chr 3:140,957,090...140,961,373
|
|
G |
Dek |
DEK proto-oncogene |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DEK mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Dennd3 |
DENN domain containing 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of DENND3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592
|
|
G |
Dgkb |
diacylglycerol kinase, beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DGKB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:54,641,614...55,397,043
|
|
G |
Dhdds |
dehydrodolichyl diphosphate synthase subunit |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DHDDS mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:146,198,359...146,224,479
Ensembl chr 5:146,197,457...146,224,454
|
|
G |
Dhx16 |
DEAH-box helicase 16 |
affects expression |
EXP |
fullerene C60 affects the expression of DHX16 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,862,000...2,874,948
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
increases expression |
EXP |
fullerene C60 results in increased expression of DHX36 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:149,006,089...149,044,192
Ensembl chr 2:146,856,469...146,894,572
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DIO3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DKC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:157,751,651...157,757,796
|
|
G |
Dlk2 |
delta like non-canonical Notch ligand 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of DLK2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:14,676,562...14,681,594
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DLL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dlx2 |
distal-less homeobox 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DLX2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:76,777,912...76,781,255
Ensembl chr 3:56,370,483...56,373,597
|
|
G |
Dlx5 |
distal-less homeobox 5 |
increases expression |
EXP |
fullerene C60 results in increased expression of DLX5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmrta2 |
DMRT-like family A2 |
increases expression |
EXP |
fullerene C60 results in increased expression of DMRTA2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:130,034,473...130,040,283
Ensembl chr 5:124,805,883...124,811,630
|
|
G |
Dmtn |
dematin actin binding protein |
increases expression |
EXP |
fullerene C60 results in increased expression of DMTN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601
|
|
G |
Dnaaf1 |
dynein, axonemal, assembly factor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNAAF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:64,532,859...64,560,942
Ensembl chr19:47,624,181...47,652,313
|
|
G |
Dnah1 |
dynein, axonemal, heavy chain 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNAH1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,456,002...6,518,350
|
|
G |
Dnah17 |
dynein, axonemal, heavy chain 17 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNAH17 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:103,748,033...103,862,009
Ensembl chr10:103,249,363...103,364,901
|
|
G |
Dnajb13 |
DnaJ heat shock protein family (Hsp40) member B13 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNAJB13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963
|
|
G |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
affects expression |
EXP |
fullerene C60 affects the expression of DNAJB5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:57,176,845...57,185,490
|
|
G |
Dnase2b |
deoxyribonuclease 2 beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNASE2B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:235,470,915...235,515,211
Ensembl chr 2:235,470,919...235,486,295
|
|
G |
Dnm1l |
dynamin 1-like |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DNM1L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Doc2b |
double C2 domain beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DOC2B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:61,126,295...61,151,533
Ensembl chr10:60,628,029...60,653,267
|
|
G |
Dpp9 |
dipeptidyl peptidase 9 |
increases expression |
EXP |
fullerene C60 results in increased expression of DPP9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:1,011,347...1,046,337
Ensembl chr 9:1,011,351...1,046,541
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DRD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DRD3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd5 |
dopamine receptor D5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DRD5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:76,700,244...76,703,344
Ensembl chr14:72,489,347...72,490,774
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
increases expression |
EXP |
fullerene C60 results in increased expression of DSN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
|
|
G |
Dtnb |
dystrobrevin, beta |
increases expression |
EXP |
fullerene C60 results in increased expression of DTNB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:32,286,022...32,483,007
Ensembl chr 6:26,566,925...26,766,335
|
|
G |
Dusp15 |
dual specificity phosphatase 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DUSP15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:161,868,746...161,880,432
Ensembl chr 3:141,408,498...141,418,999
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of DUSP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
Dusp7 |
dual specificity phosphatase 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DUSP7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
|
|
G |
Dusp9 |
dual specificity phosphatase 9 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of DUSP9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of DYRK2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EBP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Edc4 |
enhancer of mRNA decapping 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EDC4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758
|
|
G |
Edn3 |
endothelin 3 |
affects expression |
EXP |
fullerene C60 affects the expression of EDN3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:163,562,520...163,585,093
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
affects expression |
EXP |
fullerene C60 affects the expression of EEF1A2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EEF1G mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:205,860,698...205,872,382
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
increases expression |
EXP |
fullerene C60 results in increased expression of EEF2K mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Eeig2 |
EEIG family member 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EEIG2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of EEPD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EFHD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Efna3 |
ephrin A3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EFNA3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:174,729,764...174,738,736
|
|
G |
Efnb3 |
ephrin B3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EFNB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,274,506...54,280,471
|
|
G |
Egln2 |
egl-9 family hypoxia-inducible factor 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of EGLN2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:91,579,205...91,586,985
Ensembl chr 1:82,451,555...82,459,751
|
|
G |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of EHBP1L1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:202,994,118...203,014,270
|
|
G |
Ehd1 |
EH-domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EHD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212
|
|
G |
Ehd3 |
EH-domain containing 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of EHD3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:21,639,290...21,665,236
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of EHMT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
EXP |
fullerene C60 results in increased expression of EIF3B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EIF6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ELF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Eln |
elastin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ELN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Eml1 |
EMAP like 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EML1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246
|
|
G |
Eng |
endoglin |
increases expression |
EXP |
fullerene C60 results in increased expression of ENG mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Engase |
endo-beta-N-acetylglucosaminidase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ENGASE mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:103,707,169...103,719,833
Ensembl chr10:103,707,169...103,719,819
|
|
G |
Entr1 |
endosome associated trafficking regulator 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ENTR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:29,599,059...29,605,780
Ensembl chr 3:9,200,967...9,207,688
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ENTREP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
|
|
G |
Epha4 |
Eph receptor A4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EPHA4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Epha8 |
Eph receptor A8 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EPHA8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399
|
|
G |
Ephb2 |
Eph receptor B2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EPHB2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
EXP |
fullerene C60 results in increased expression of EPHB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:93,345,098...93,363,775
Ensembl chr11:79,840,668...79,859,370
|
|
G |
Ephx3 |
epoxide hydrolase 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EPHX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:11,206,812...11,212,122
Ensembl chr 7:11,206,812...11,212,122
|
|
G |
Epn2 |
epsin 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of EPN2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,197,785...46,259,642
|
|
G |
Epor |
erythropoietin receptor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EPOR mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
increases expression |
EXP |
fullerene C60 results in increased expression of ERCC4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,419,038...2,448,369 Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ERCC5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ergic2 |
ERGIC and golgi 2 |
affects expression |
EXP |
fullerene C60 affects the expression of ERGIC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Espn |
espin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ESPN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
|
|
G |
Ess2 |
ess-2 splicing factor homolog |
increases expression |
EXP |
fullerene C60 results in increased expression of ESS2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ETNK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Etv3 |
ETS variant transcription factor 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ETV3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:172,965,588...172,980,314
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of ETV4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
increases expression |
EXP |
fullerene C60 results in increased expression of ETV5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Eva1b |
eva-1 homolog B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EVA1B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
|
|
G |
Exoc3l1 |
exocyst complex component 3-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of EXOC3L1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:33,166,836...33,174,371
Ensembl chr19:33,166,837...33,172,486
|
|
G |
Exosc8 |
exosome component 8 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EXOSC8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Exph5 |
exophilin 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EXPH5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
|
|
G |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of EYA4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976
|
|
G |
F10 |
coagulation factor X |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F12 |
coagulation factor XII |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F12 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F2R mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F2RL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:26,772,278...26,785,226
|
|
G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F2RL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:26,972,054...26,977,098
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of F2RL3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,117,441...17,119,472
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAIM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam120b |
family with sequence similarity 120 member B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAM120B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:56,320,015...56,385,064
Ensembl chr 1:56,339,129...56,385,061
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
increases expression |
EXP |
fullerene C60 results in increased expression of FAM13B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,040,285...26,106,587
|
|
G |
Fam151a |
family with sequence similarity 151, member A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAM151A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555
|
|
G |
Fam168a |
family with sequence similarity 168, member A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAM168A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:164,469,447...164,615,542
Ensembl chr 1:155,057,352...155,201,220
|
|
G |
Fam20b |
FAM20B, glycosaminoglycan xylosylkinase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAM20B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:71,351,834...71,390,192
Ensembl chr13:68,801,669...68,839,915
|
|
G |
Fam234a |
family with sequence similarity 234, member A |
increases expression |
EXP |
fullerene C60 results in increased expression of FAM234A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:15,232,267...15,263,529
Ensembl chr10:15,232,278...15,263,488
|
|
G |
Fam98c |
family with sequence similarity 98, member C |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FAM98C mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:93,580,286...93,583,894
Ensembl chr 1:84,452,814...84,456,385
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of FARP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:104,531,196...104,770,148
Ensembl chr15:98,182,329...98,363,299
|
|
G |
Fbll1 |
fibrillarin-like 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FBLL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:20,258,656...20,260,299
Ensembl chr10:20,258,656...20,260,299
|
|
G |
Fbn2 |
fibrillin 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FBN2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:53,696,197...53,901,992
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbxl13 |
F-box and leucine-rich repeat protein 13 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FBXL13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:13,414,880...13,607,079
Ensembl chr 4:13,414,926...13,641,494
|
|
G |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FBXL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:122,794,870...122,843,265
Ensembl chr 8:113,913,373...113,965,066
|
|
G |
Fbxo2 |
F-box protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FBXO2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355
|
|
G |
Fbxo39 |
F-box protein 39 |
increases expression |
EXP |
fullerene C60 results in increased expression of FBXO39 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:57,428,259...57,433,468
Ensembl chr10:56,932,297...56,934,906
|
|
G |
Fbxw5 |
F-box and WD repeat domain containing 5 |
increases expression |
EXP |
fullerene C60 results in increased expression of FBXW5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:8,322,543...8,327,092
|
|
G |
Fcnb |
ficolin B |
increases expression |
EXP |
fullerene C60 results in increased expression of FCNB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
increases expression |
EXP |
fullerene C60 results in increased expression of FES mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:134,337,698...134,346,934
|
|
G |
Fgd2 |
FYVE, RhoGEF and PH domain containing 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of FGD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FGF2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of FGFR4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fgl2 |
fibrinogen-like 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FGL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fh |
fumarate hydratase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FH mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:90,056,565...90,082,450
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fhip2b |
FHF complex subunit HOOK interacting protein 2B |
increases expression |
EXP |
fullerene C60 results in increased expression of FHIP2B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:52,066,341...52,084,296
Ensembl chr15:45,656,647...45,674,105
|
|
G |
Fhod1 |
formin homology 2 domain containing 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FHOD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:33,206,492...33,225,448
Ensembl chr19:33,206,492...33,225,356
|
|
G |
Fibin |
fin bud initiation factor homolog |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FIBIN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of FKBP4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
affects expression |
EXP |
fullerene C60 affects the expression of FKBP5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flg |
filaggrin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FLG mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:181,583,801...181,596,464
|
|
G |
Flnb |
filamin B |
increases expression |
EXP |
fullerene C60 results in increased expression of FLNB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FLT1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmnl1 |
formin-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of FMNL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:88,115,876...88,143,342
Ensembl chr10:88,116,009...88,143,357
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of FMO3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:77,838,899...77,868,869
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fndc7 |
fibronectin type III domain containing 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of FNDC7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:196,501,313...196,537,816
Ensembl chr 2:196,502,460...196,537,694
|
|
G |
Fndc8 |
fibronectin type III domain containing 8 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FNDC8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:67,825,952...67,834,090
Ensembl chr10:67,825,952...67,834,090
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
increases expression |
EXP |
fullerene C60 results in increased expression of FNTB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:101,269,657...101,352,716
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Folr1 |
folate receptor alpha |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOLR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
fullerene C60 results in increased expression of FOS mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOSL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOSL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxb1 |
forkhead box B1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:79,288,161...79,290,781
Ensembl chr 8:70,408,186...70,409,781
|
|
G |
Foxc2 |
forkhead box C2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:66,094,718...66,097,420
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxn1 |
forkhead box N1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:63,749,461...63,778,468
Ensembl chr10:63,251,400...63,273,710
|
|
G |
Foxn4 |
forkhead box N4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXN4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:47,997,308...48,020,526
Ensembl chr12:42,340,323...42,359,921
|
|
G |
Foxo3 |
forkhead box O3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXO3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxred2 |
FAD-dependent oxidoreductase domain containing 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FOXRED2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:109,521,761...109,540,874
|
|
G |
Frem2 |
FRAS1 related extracellular matrix 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FREM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:139,753,055...139,891,046
Ensembl chr 2:137,602,784...137,740,785
|
|
G |
Frmd4a |
FERM domain containing 4A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FRMD4A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
|
|
G |
Frmd4b |
FERM domain containing 4B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of FRMD4B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of FSTL3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fxr2 |
FMR1 autosomal homolog 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of FXR2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:54,849,345...54,869,713
Ensembl chr10:54,350,131...54,370,964
|
|
G |
Fzd2 |
frizzled class receptor 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of FZD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Gab2 |
GRB2-associated binding protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GAB2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
|
|
G |
Gabrq |
gamma-aminobutyric acid type A receptor subunit theta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GABRQ mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:155,737,838...155,755,225
Ensembl chr X:150,696,427...150,709,919
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GALNT16 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Gapdhs |
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GAPDHS mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640
|
|
G |
Garin1b |
golgi associated RAB2 interactor 1B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GARIN1B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591
|
|
G |
Gas2 |
growth arrest-specific 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GAS2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gas7 |
growth arrest specific 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of GAS7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,152,493...52,383,276
|
|
G |
Gast |
gastrin |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GAST mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gatad2a |
GATA zinc finger domain containing 2A |
increases expression |
EXP |
fullerene C60 results in increased expression of GATAD2A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GBX2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:97,957,304...97,959,883
Ensembl chr 9:90,509,633...90,512,212
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GCLM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gda |
guanine deaminase |
increases expression |
EXP |
fullerene C60 results in increased expression of GDA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GDAP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:6,715,935...6,735,013
Ensembl chr 5:1,932,613...2,030,061
|
|
G |
Gdf15 |
growth differentiation factor 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GDF15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf5 |
growth differentiation factor 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GDF5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:144,454,338...144,458,612
|
|
G |
Gdf7 |
growth differentiation factor 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GDF7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:31,171,495...31,182,484
Ensembl chr 6:31,178,119...31,182,447
|
|
G |
Ghdc |
GH3 domain containing |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GHDC mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:85,693,612...85,697,833
Ensembl chr10:85,693,616...85,697,865
|
|
G |
Ghrh |
growth hormone releasing hormone |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GHRH mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:145,992,763...146,011,889
|
|
G |
Giot1 |
gonadotropin inducible ovarian transcription factor 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GIOT1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:10,868,517...10,886,965
Ensembl chr 7:10,202,982...10,237,099
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GIPC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:41,380,125...41,392,078
Ensembl chr19:24,453,123...24,486,997
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of GIPC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GJA4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GJB1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb4 |
gap junction protein, beta 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GJB4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:144,948,231...144,964,014
Ensembl chr 5:139,675,780...139,679,667
|
|
G |
Gjb5 |
gap junction protein, beta 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GJB5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:139,680,670...139,683,588
Ensembl chr 5:139,680,671...139,683,583
|
|
G |
Gjd4 |
gap junction protein, delta 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GJD4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:57,348,844...57,352,601
Ensembl chr17:57,349,877...57,352,446
|
|
G |
Glis2 |
GLIS family zinc finger 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of GLIS2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:11,457,594...11,484,948
Ensembl chr10:10,951,371...10,971,578
|
|
G |
Glmn |
glomulin, FKBP associated protein |
increases expression |
EXP |
fullerene C60 results in increased expression of GLMN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
increases expression |
EXP |
fullerene C60 results in increased expression of GLP1R mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,972,004...9,010,241
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
increases expression |
EXP |
fullerene C60 results in increased expression of GMNN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,301,808...40,310,054
|
|
G |
Gna12 |
G protein subunit alpha 12 |
increases expression |
EXP |
fullerene C60 results in increased expression of GNA12 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:13,805,698...13,886,255
|
|
G |
Gna15 |
G protein subunit alpha 15 |
increases expression |
EXP |
fullerene C60 results in increased expression of GNA15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Gnal |
G protein subunit alpha L |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GNAL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:62,892,257...63,032,510
Ensembl chr18:60,622,311...60,762,599
|
|
G |
Gnb2 |
G protein subunit beta 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of GNB2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:24,795,505...24,800,796
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Gng2 |
G protein subunit gamma 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GNG2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,316,059...4,417,183
|
|
G |
Golga3 |
golgin A3 |
increases expression |
EXP |
fullerene C60 results in increased expression of GOLGA3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GOSR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
|
|
G |
Gosr2 |
golgi SNAP receptor complex member 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GOSR2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:89,085,323...89,105,665
Ensembl chr10:88,586,299...88,605,625
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of GOT2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gp1bb |
glycoprotein Ib platelet subunit beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GP1BB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:95,882,561...95,883,738
Ensembl chr11:82,378,199...82,379,392
|
|
G |
Gpatch2 |
G patch domain containing 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPATCH2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:101,316,413...101,457,109
Ensembl chr13:98,784,969...98,925,661
|
|
G |
Gpbp1 |
GC-rich promoter binding protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GPBP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:43,023,504...43,090,907
|
|
G |
Gpihbp1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
affects expression |
EXP |
fullerene C60 affects the expression of GPIHBP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:107,285,654...107,288,702
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
increases expression |
EXP |
fullerene C60 results in increased expression of GPR146 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:20,365,790...20,381,122
Ensembl chr12:15,251,813...15,267,206
|
|
G |
Gpr15 |
G protein-coupled receptor 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:55,367,496...55,368,842
Ensembl chr11:41,898,356...41,900,441
|
|
G |
Gpr153 |
G protein-coupled receptor 153 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR153 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
|
|
G |
Gpr156 |
G protein-coupled receptor 156 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR156 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:62,722,632...62,815,402
Ensembl chr11:62,723,872...62,815,435
|
|
G |
Gpr157 |
G protein-coupled receptor 157 |
increases expression |
EXP |
fullerene C60 results in increased expression of GPR157 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:165,833,651...165,849,376
Ensembl chr 5:160,550,713...160,566,432
|
|
G |
Gpr162 |
G protein-coupled receptor 162 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR162 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:159,348,465...159,354,577
Ensembl chr 4:157,662,200...157,668,121
|
|
G |
Gpr22 |
G protein-coupled receptor 22 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR22 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:54,037,998...54,044,994
Ensembl chr 6:48,310,505...48,317,486
|
|
G |
Gpr3 |
G protein-coupled receptor 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPR3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:145,411,500...145,414,621
Ensembl chr 5:145,411,510...145,414,590
|
|
G |
Gprasp3 |
G protein-coupled receptor associated sorting protein family member 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPRASP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:98,847,591...98,854,949
Ensembl chr X:98,817,593...98,854,545
|
|
G |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPRIN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,863,571...9,876,915
|
|
G |
Gpsm1 |
G-protein signaling modulator 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPSM1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:9,128,636...9,167,827
|
|
G |
Gpsm3 |
G-protein signaling modulator 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPSM3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,157,123...4,159,035
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of GPX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx6 |
glutathione peroxidase 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GPX6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRB10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grem1 |
gremlin 1, DAN family BMP antagonist |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GREM1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:100,512,313...100,524,082
|
|
G |
Grem2 |
gremlin 2, DAN family BMP antagonist |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GREM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:89,310,897...89,403,856
Ensembl chr13:86,778,500...86,871,615
|
|
G |
Grik1 |
glutamate ionotropic receptor kainate type subunit 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRIK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:40,655,974...41,056,966
Ensembl chr11:27,169,740...27,570,645
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRIN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2d |
glutamate ionotropic receptor NMDA type subunit 2D |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRIN2D mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:96,308,365...96,344,793
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GRINA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grk1 |
G protein-coupled receptor kinase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:76,122,501...76,135,792
Ensembl chr16:76,123,842...76,135,792
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GRK6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,177,019...9,192,644
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression |
EXP |
fullerene C60 results in increased expression of GSTM4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5l |
glutathione S-transferase, mu 5-like |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GSTM5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gsx1 |
GS homeobox 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GSX1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:12,994,588...12,996,874
Ensembl chr12:7,881,460...7,882,753
|
|
G |
Gtf2h2 |
general transcription factor IIH subunit 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GTF2H2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:31,623,752...31,652,697
Ensembl chr 2:31,624,678...31,652,592
|
|
G |
Gtf2ird1 |
GTF2I repeat domain containing 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GTF2IRD1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:27,890,594...27,997,506
Ensembl chr12:22,254,221...22,361,040
|
|
G |
Gtf3c1 |
general transcription factor IIIC subunit 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GTF3C1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:180,203,995...180,270,201
|
|
G |
Gtpbp2 |
GTP binding protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of GTPBP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:22,311,532...22,321,405
Ensembl chr 9:14,813,964...14,823,241
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of GTSE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gys1 |
glycogen synthase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GYS1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
Gys2 |
glycogen synthase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GYS2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
Gzmb |
granzyme B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of GZMB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:30,173,603...30,346,814
|
|
G |
H2ab3 |
H2A.B variant histone 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of H2AB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:86,566,994...86,567,568
Ensembl chr X:82,362,633...82,362,983
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HACL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,824,906...6,863,027
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
increases expression |
EXP |
fullerene C60 results in increased expression of HAMP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hand1 |
heart and neural crest derivatives expressed 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HAND1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:42,507,117...42,509,684
Ensembl chr10:42,006,651...42,009,213
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243
|
|
G |
Haus7 |
HAUS augmin-like complex, subunit 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of HAUS7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:151,154,979...151,174,441
Ensembl chr X:151,154,979...151,180,577
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HAVCR1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HAVCR2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:30,882,606...30,909,137
|
|
G |
Hbe1 |
hemoglobin subunit epsilon 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HBE1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:167,694,820...167,872,091
Ensembl chr 1:158,282,936...158,284,391
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
increases expression |
EXP |
fullerene C60 results in increased expression of HCRT mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
|
|
G |
Hdac1 |
histone deacetylase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HDAC1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HDAC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac5 |
histone deacetylase 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HDAC5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hdac7 |
histone deacetylase 7 |
increases expression |
EXP |
fullerene C60 results in increased expression of HDAC7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:128,923,920...128,962,072
|
|
G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HECW2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:55,365,203...55,580,327
|
|
G |
Helz2 |
helicase with zinc finger 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of HELZ2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hes3 |
hes family bHLH transcription factor 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HES3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:168,076,337...168,082,270
Ensembl chr 5:162,794,367...162,796,261
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
affects expression |
EXP |
fullerene C60 affects the expression of HES5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HIF3A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hint3 |
histidine triad nucleotide binding protein 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of HINT3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:28,854,860...28,864,723
Ensembl chr 1:27,035,905...27,047,721
|
|
G |
Hip1r |
huntingtin interacting protein 1 related |
increases expression |
EXP |
fullerene C60 results in increased expression of HIP1R mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:32,590,165...32,618,734
|
|
G |
Hist1h2bo |
histone cluster 1 H2B family member O |
increases expression |
EXP |
fullerene C60 results in increased expression of H2BC15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:47,412,176...47,413,789
Ensembl chr17:42,673,067...42,718,095 Ensembl chr17:42,673,067...42,718,095
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
increases expression |
EXP |
fullerene C60 results in increased expression of HIST2H2BE mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:186,469,452...186,471,899
|
|
G |
Hivep1 |
HIVEP zinc finger 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HIVEP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,585,016...22,711,956
|
|
G |
Hjurp |
Holliday junction recognition protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HJURP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:88,853,386...88,867,728
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
increases expression |
EXP |
fullerene C60 results in increased expression of HJV mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hk1 |
hexokinase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hlcs |
holocarboxylase synthetase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HLCS mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgb1 |
high mobility group box 1 |
increases secretion multiple interactions |
ISO |
fullerene C60 results in increased secretion of HMGB1 protein 2',3'-dialdehyde ATP inhibits the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; [[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein; Adenosine Triphosphate promotes the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; fullerene C60 results in increased localization of and results in increased secretion of HMGB1 protein; P2RX7 protein affects the reaction [fullerene C60 results in increased secretion of HMGB1 protein] |
CTD |
PMID:31504961 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgcl |
3-hydroxy-3-methylglutaryl-CoA lyase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HMGCL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:148,178,252...148,192,068
|
|
G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HMGN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:48,891,813...48,897,732
Ensembl chr11:35,422,328...35,428,254
|
|
G |
Hmx2 |
H6 family homeobox 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HMX2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:195,749,284...195,758,347
Ensembl chr 1:186,319,110...186,326,771
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HNF4A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnrnpll |
heterogeneous nuclear ribonucleoprotein L-like |
increases expression |
EXP |
fullerene C60 results in increased expression of HNRNPLL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:20,720,013...20,752,803
Ensembl chr 6:14,970,057...14,999,745
|
|
G |
Hoga1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HOGA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:240,857,126...240,884,568
|
|
G |
Hopx |
HOP homeobox |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HOPX mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,075,148...31,082,909
|
|
G |
Hoxc5 |
homeo box C5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HOXC5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:136,029,454...136,032,876
Ensembl chr 7:134,150,988...134,154,410
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HPCAL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hpn |
hepsin |
increases expression |
EXP |
fullerene C60 results in increased expression of HPN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:86,337,087...86,352,811
|
|
G |
Hps1 |
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HPS1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268
|
|
G |
Hrh4 |
histamine receptor H4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HRH4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:4,440,977...4,457,132
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of HS6ST1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:38,283,502...38,322,684
Ensembl chr 9:38,282,395...38,322,683
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hspa12b |
heat shock protein family A (Hsp70) member 12B |
increases expression |
EXP |
fullerene C60 results in increased expression of HSPA12B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
affects expression |
EXP |
fullerene C60 affects the expression of HSPA1A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HSPA1L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
EXP |
fullerene C60 results in increased expression of HSPA8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb3 |
heat shock protein family B (small) member 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HSPB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:45,295,285...45,295,999
Ensembl chr 2:45,295,053...45,296,145
|
|
G |
Hspb7 |
heat shock protein family B (small) member 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HSPB7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
|
|
G |
Hspd1l2 |
heat shock protein family D (Hsp60) member 1 like 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of HSPD1L2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:107,131,587...107,131,895
Ensembl chr 5:107,131,587...107,131,895
|
|
G |
Htr5b |
5-hydroxytryptamine (serotonin) receptor 5B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HTR5B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:35,239,662...35,252,586
Ensembl chr13:32,687,042...32,699,835
|
|
G |
Htra3 |
HtrA serine peptidase 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of HTRA3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:79,293,535...79,321,936
Ensembl chr14:75,068,917...75,097,315
|
|
G |
Hyal2 |
hyaluronidase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HYAL2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:108,243,133...108,246,850
|
|
G |
Hykk |
hydroxylysine kinase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of HYKK mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:55,315,969...55,337,339
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IDH3B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of IDI1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier5l |
immediate early response 5-like |
increases expression |
EXP |
fullerene C60 results in increased expression of IER5L mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:13,744,078...13,745,647
|
|
G |
Iffo1 |
intermediate filament family orphan 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of IFFO1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:159,631,309...159,648,531
Ensembl chr 4:157,945,107...157,962,302
|
|
G |
Ifi30 |
IFI30, lysosomal thiol reductase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IFI30 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
|
|
G |
Ifng |
interferon gamma |
increases secretion |
ISO |
fullerene C60 results in increased secretion of IFNG protein |
CTD |
PMID:20064541 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ift27 |
intraflagellar transport 27 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IFT27 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:109,738,622...109,754,416
|
|
G |
Ift43 |
intraflagellar transport 43 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IFT43 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:111,460,689...111,537,224
Ensembl chr 6:105,729,792...105,806,257
|
|
G |
Iftap |
intraflagellar transport associated protein |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IFTAP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:108,242,105...108,361,607
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IGF1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Ighmbp2 |
immunoglobulin mu DNA binding protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of IGHMBP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:209,935,922...209,958,570
Ensembl chr 1:200,506,338...200,529,514
|
|
G |
Igsf3 |
immunoglobulin superfamily, member 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IGSF3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
fullerene C60 results in increased secretion of IL10 protein |
CTD |
PMID:20064541 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il17ra |
interleukin 17 receptor A |
increases expression |
EXP |
fullerene C60 results in increased expression of IL17RA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:153,667,534...153,690,174
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IL1B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
increases secretion |
ISO |
fullerene C60 results in increased secretion of IL2 protein |
CTD |
PMID:20064541 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il21r |
interleukin 21 receptor |
increases expression |
EXP |
fullerene C60 results in increased expression of IL21R mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:180,168,097...180,195,522
|
|
G |
Il22ra1 |
interleukin 22 receptor subunit alpha 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IL22RA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:147,961,349...147,986,296
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IL2RG mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:70,435,340...70,439,052
Ensembl chr X:66,392,542...66,399,823
|
|
G |
Il33 |
interleukin 33 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IL33 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4r |
interleukin 4 receptor |
increases expression |
EXP |
fullerene C60 results in increased expression of IL4RA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion |
ISO |
fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein] fullerene C60 results in increased secretion of IL6 protein |
CTD |
PMID:19376187 PMID:20064541 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilvbl |
ilvB acetolactate synthase like |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ILVBL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:11,690,445...11,700,498
Ensembl chr 7:11,039,871...11,049,924
|
|
G |
Impa2 |
inositol monophosphatase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IMPA2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:60,834,246...60,865,641
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of INHBA mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of INPP4B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:42,824,710...43,575,039
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of INPPL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:165,595,047...165,609,503
Ensembl chr 1:156,183,059...156,197,500
|
|
G |
Ints7 |
integrator complex subunit 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of INTS7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:105,686,208...105,739,609
Ensembl chr13:103,155,090...103,208,592
|
|
G |
Ipo5 |
importin 5 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IPO5 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:104,397,626...104,447,985
Ensembl chr15:98,005,299...98,041,126
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IQGAP3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:173,542,110...173,583,956
|
|
G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IRAK1BP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:92,608,468...92,628,377
Ensembl chr 8:83,731,507...83,748,289
|
|
G |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IRF2BPL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:106,528,053...106,530,401
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of IRF7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irx1 |
iroquois homeobox 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of IRX1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:33,123,122...33,128,951
Ensembl chr 1:31,294,615...31,300,444
|
|
G |
Irx3 |
iroquois homeobox 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of IRX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:31,384,803...31,388,241
Ensembl chr19:15,211,878...15,215,317
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ISCA1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,905,287...4,917,955
|
|
G |
Itga7 |
integrin subunit alpha 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ITGA7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
EXP |
fullerene C60 results in increased expression of ITGAM mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb1bp2 |
integrin subunit beta 1 binding protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ITGB1BP2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr X:70,612,118...70,617,158
Ensembl chr X:66,572,537...66,577,174
|
|
G |
Itgb3 |
integrin subunit beta 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of ITGB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of ITPR3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Itsn1 |
intersectin 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of ITSN1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:44,464,515...44,646,598
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Ivd |
isovaleryl-CoA dehydrogenase |
increases expression |
EXP |
fullerene C60 results in increased expression of IVD mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:105,851,683...105,872,575
|
|
G |
Jade2 |
jade family PHD finger 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of JADE2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
|
|
G |
Jag2 |
jagged canonical Notch ligand 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of JAG2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:131,983,056...132,005,818
|
|
G |
Jchain |
joining chain of multimeric IgA and IgM |
decreases expression |
EXP |
fullerene C60 results in decreased expression of JCHAIN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,538,952...19,546,298
|
|
G |
Jph1 |
junctophilin 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of JPH1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:6,813,553...6,920,488
Ensembl chr 5:2,030,281...2,125,284
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
fullerene C60 results in increased expression of JUNB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
fullerene C60 results in increased expression of JUND mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Jup |
junction plakoglobin |
increases expression |
EXP |
fullerene C60 results in increased expression of JUP mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,300,440...85,327,057
|
|
G |
Kalrn |
kalirin, RhoGEF kinase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KALRN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:66,198,173...66,797,610
|
|
G |
Kansl3 |
KAT8 regulatory NSL complex subunit 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of KANSL3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:38,562,170...38,605,757
Ensembl chr 9:38,562,177...38,605,692
|
|
G |
Kat14 |
lysine acetyltransferase 14 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KAT14 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706
|
|
G |
Kcng2 |
potassium voltage-gated channel modifier subfamily G member 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KCNG2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723
|
|
G |
Kcnn3 |
potassium calcium-activated channel subfamily N member 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of KCNN3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:177,227,276...177,378,849
Ensembl chr 2:174,936,629...175,081,145
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of KCNQ1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Kctd13 |
potassium channel tetramerization domain containing 13 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KCTD13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:181,534,534...181,552,843
Ensembl chr 1:181,534,515...181,552,881
|
|
G |
Kdm4c |
lysine demethylase 4C |
affects expression |
EXP |
fullerene C60 affects the expression of KDM4C mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:93,146,404...93,353,040
Ensembl chr 5:88,100,733...88,306,818
|
|
G |
Kdm6b |
lysine demethylase 6B |
increases expression |
EXP |
fullerene C60 results in increased expression of KDM6B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:54,619,520...54,641,014
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
EXP |
fullerene C60 results in increased expression of KEAP1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kel |
Kell metallo-endopeptidase (Kell blood group) |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KEL mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:71,534,882...71,552,297
Ensembl chr 4:70,568,243...70,585,631
|
|
G |
Kiaa1671 |
KIAA1671 homolog |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KIAA1671 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157
|
|
G |
Kif20b |
kinesin family member 20B |
increases expression |
EXP |
fullerene C60 results in increased expression of KIF20B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Kif26a |
kinesin family member 26A |
increases expression |
EXP |
fullerene C60 results in increased expression of KIF26A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:131,214,839...131,250,874
Ensembl chr 6:131,214,861...131,250,320
|
|
G |
Kifc3 |
kinesin family member C3 |
decreases expression increases expression |
EXP |
fullerene C60 results in decreased expression of KIFC3 mRNA fullerene C60 results in increased expression of KIFC3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
|
|
G |
Kirrel1 |
kirre like nephrin family adhesion molecule 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KIRREL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299
|
|
G |
Klc3 |
kinesin light chain 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLC3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:79,045,842...79,055,809
Ensembl chr 1:79,045,844...79,055,416
|
|
G |
Klf11 |
KLF transcription factor 11 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLF11 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:41,285,842...41,297,550
|
|
G |
Klf15 |
KLF transcription factor 15 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLF15 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf7 |
KLF transcription factor 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLF7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:65,437,167...65,526,261
|
|
G |
Klf9 |
KLF transcription factor 9 |
affects expression |
EXP |
fullerene C60 affects the expression of KLF9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Klhdc3 |
kelch domain containing 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHDC3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:14,302,345...14,308,736
Ensembl chr 9:14,302,354...14,308,736
|
|
G |
Klhdc8b |
kelch domain containing 8B |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHDC8B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:118,020,136...118,025,102
Ensembl chr 8:109,141,594...109,146,918
|
|
G |
Klhl18 |
kelch-like family member 18 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHL18 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:110,400,679...110,459,442
Ensembl chr 8:110,400,681...110,459,323
|
|
G |
Klhl21 |
kelch-like family member 21 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHL21 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545
|
|
G |
Klhl22 |
kelch-like family member 22 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHL22 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr11:96,695,168...96,736,079
Ensembl chr11:83,190,891...83,231,770
|
|
G |
Klhl25 |
kelch-like family member 25 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHL25 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:139,134,655...139,159,898
Ensembl chr 1:129,722,026...129,750,227
|
|
G |
Klhl42 |
kelch-like family, member 42 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLHL42 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:181,730,343...181,760,899
Ensembl chr 4:180,004,580...180,027,283
|
|
G |
Klhl7 |
kelch-like family member 7 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLHL7 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:11,898,766...11,947,796
Ensembl chr 4:11,006,375...11,055,541
|
|
G |
Klk1 |
kallikrein 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLK1C10 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Klk9 |
kallikrein related-peptidase 9 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KLK9 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:94,246,339...94,250,631
Ensembl chr 1:94,246,339...94,250,631
|
|
G |
Klrc2 |
killer cell lectin like receptor C2 |
increases expression |
EXP |
fullerene C60 results in increased expression of KLRC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:164,808,722...164,819,865
Ensembl chr 4:163,122,704...163,133,843
|
|
G |
Kmt5b |
lysine methyltransferase 5B |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KMT5B mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:201,000,444...201,049,819
|
|
G |
Kmt5c |
lysine methyltransferase 5C |
increases expression |
EXP |
fullerene C60 results in increased expression of KMT5C mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:69,099,531...69,107,145
Ensembl chr 1:69,099,539...69,107,145
|
|
G |
Krt13 |
keratin 13 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KRT13 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,051,889...85,056,084
|
|
G |
Krt8 |
keratin 8 |
increases expression |
EXP |
fullerene C60 results in increased expression of KRT8 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Krtap3-3 |
keratin associated protein 3-3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KRTAP3-3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:84,511,459...84,511,758
Ensembl chr10:84,511,092...84,511,812 Ensembl chr10:84,511,092...84,511,812
|
|
G |
Ky |
kyphoscoliosis peptidase |
decreases expression |
EXP |
fullerene C60 results in decreased expression of KY mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:111,965,862...112,005,206
Ensembl chr 8:103,086,630...103,126,024
|
|
G |
Lactb |
lactamase, beta |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LACTB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:67,571,504...67,587,592
Ensembl chr 8:67,571,500...67,587,539
|
|
G |
Lamb3 |
laminin subunit beta 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LAMB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of LAMC2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lancl1 |
LanC like glutathione S-transferase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LANCL1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 9:68,515,052...68,548,646
Ensembl chr 9:68,518,574...68,548,628
|
|
G |
Larp6 |
La ribonucleoprotein 6, translational regulator |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LARP6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535
|
|
G |
Lats2 |
large tumor suppressor kinase 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LATS2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr15:35,940,632...35,992,225
Ensembl chr15:31,825,092...31,877,220
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of LCN2 mRNA |
CTD |
PMID:20471445 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldb3 |
LIM domain binding 3 |
increases expression |
EXP |
fullerene C60 results in increased expression of LDB3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr16:9,855,768...9,920,108
Ensembl chr16:9,855,927...9,918,532
|
|
G |
Ldhb |
lactate dehydrogenase B |
increases expression |
EXP |
fullerene C60 results in increased expression of LDHB mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Lemd2 |
LEM domain nuclear envelope protein 2 |
increases expression |
EXP |
fullerene C60 results in increased expression of LEMD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr20:5,284,275...5,298,281
Ensembl chr20:5,282,397...5,296,626
|
|
G |
Lemd3 |
LEM domain containing 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LEMD3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 7:58,300,556...58,389,485
Ensembl chr 7:56,305,448...56,502,474
|
|
G |
Lhfpl4 |
LHFPL tetraspan subfamily member 4 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LHFPL4 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:146,317,110...146,340,073
Ensembl chr 4:146,313,541...146,340,463
|
|
G |
Lhfpl6 |
LHFPL tetraspan subfamily member 6 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LHFPL6 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443
|
|
G |
Lhx3 |
LIM homeobox 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LHX3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 3:29,424,620...29,432,637
Ensembl chr 3:9,027,425...9,034,480
|
|
G |
Lig3 |
DNA ligase 3 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIG3 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Lim2 |
lens intrinsic membrane protein 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIM2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 1:93,837,597...93,843,769
Ensembl chr 1:93,837,597...93,843,769
|
|
G |
Limd2 |
LIM domain containing 2 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIMD2 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,090,280...91,092,775
|
|
G |
Limk1 |
LIM domain kinase 1 |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIMK1 mRNA |
CTD |
PMID:19167457 |
|
NCBI chr12:27,663,177...27,697,085
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Lin28a |
lin-28 homolog A |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIN28A mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 5:151,510,891...151,527,884
Ensembl chr 5:146,227,119...146,244,122
|
|
G |
Lipc |
lipase C, hepatic type |
decreases expression |
EXP |
fullerene C60 results in decreased expression of LIPC mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipogenin |
Lipogenin |
increases expression |
EXP |
fullerene C60 results in increased expression of LIPOGENIN mRNA |
CTD |
PMID:19167457 |
|
NCBI chr 4:57,356,298...57,357,553
|
|
G |
Lix1l |
limb and CNS expressed 1 like |
increases expression |
| |